Juxtaposition of IL-1β and IFN-γ expression and apoptosis of keratinocytes in adult-onset Still’s disease

References

• Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still’s disease. J Autoimmun. 2018;93:24–36.
   PubMed Web of Science ®Google Scholar
• Mahroum N, Mahagna H, Amital H. Diagnosis and classification of adult Still’s disease. J Autoimmun. 2014;48–49:34–37.
   PubMed Web of Science ®Google Scholar
• Bywaters EG. Still’s disease in the adult. Ann Rheum Dis. 1971;30(2):121–133.
   PubMed Web of Science ®Google Scholar
• Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset Still’s disease. Nat Rev Rheumatol. 2018;14(10):603–618.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19(3):424–430.
   PubMed Web of Science ®Google Scholar
• Fautrel B, Zing E, Golmard JL, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81(3):194–200.
   PubMed Web of Science ®Google Scholar
• Kaur S, Bambery P, Dhar S. Persistent dermal plaque lesions in adult onset Still’s disease. Dermatology. 1994;188(3):241–242.
   PubMed Web of Science ®Google Scholar
• Lee JY, Hsu CK, Liu MF, et al. Evanescent and persistent pruritic eruptions of adult-onset still disease: a clinical and pathologic study of 36 patients. Semin Arthritis Rheum. 2012;42(3):317–326.
   PubMed Web of Science ®Google Scholar
• Lubbe J, Hofer M, Chavaz P, et al. Adult-onset Still’s disease with persistent plaques. Br J Dermatol. 1999;141(4):710–713.
   PubMed Web of Science ®Google Scholar
• Narvaez Garcia FJ, Pascual M, Lopez de Recalde M, et al. Adult-onset Still’s disease with atypical cutaneous manifestations. Medicine (Baltimore). 2017;96(11):e6318.
   PubMed Web of Science ®Google Scholar
• Qiao J, Zhou S, Li S, et al. Histopathological diagnosis of persistent pruritic eruptions associated with adult-onset Still’s disease. Histopathology. 2019;74(5):759–765.
   PubMed Web of Science ®Google Scholar
• Sun NZ, Brezinski EA, Berliner J, et al. Updates in adult-onset Still disease: atypical cutaneous manifestations and associations with delayed malignancy. J Am Acad Dermatol. 2015;73(2):294–303.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kimura Y, Aoki M, et al. Persistent plaques and linear pigmentation in adult-onset Still’s disease. Dermatology. 2001;202(4):333–335.
   PubMed Web of Science ®Google Scholar
• Zuelgaray E, Battistella M, Sal le de Chou C, et al. Increased severity and epidermal alterations in persistent versus evanescent skin lesions in adult-onset Still disease. J Am Acad Dermatol. 2018;79(5):969–971.
   PubMed Web of Science ®Google Scholar
• Lee JY, Yang CC, Hsu MM. Histopathology of persistent papules and plaques in adult-onset Still’s disease. J Am Acad Dermatol. 2005;52(6):1003–1008.
   PubMed Web of Science ®Google Scholar
• Yamamoto T. Cutaneous manifestations associated with adult-onset Still’s disease: important diagnostic values. Rheumatol Int. 2012;32(8):2233–2237.
   PubMed Web of Science ®Google Scholar
• Kikuchi N, Satoh M, Ohtsuka M, et al. Persistent pruritic papules and plaques associated with adult-onset Still’s disease: report of six cases. J Dermatol. 2014;41(5):407–410.
   PubMed Web of Science ®Google Scholar
• Larson AR, Laga AC, Granter SR. The spectrum of histopathologic findings in cutaneous lesions in patients with Still disease. Am J Clin Pathol. 2015;144(6):945–951.
   PubMed Web of Science ®Google Scholar
• Santa E, McFalls JM, Sahu J, et al. Clinical and histopathological features of cutaneous manifestations of adult-onset Still disease. J Cutan Pathol. 2017;44(6):591–595.
   PubMed Web of Science ®Google Scholar
• Shiitake NT. (Lentinus edodes) dermatitis. Contact Dermatitis. 1992;27(2):65–70.
   PubMed Web of Science ®Google Scholar
• Poppe LM, Anders D, Kneitz H, et al. Flagellate dermatitis caused by shiitake mushrooms. An Bras Dermatol. 2012;87(3):463–465.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Cipriani P, Ciccia F, et al. H-ferritin and CD68(+)/H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still’s disease patients and correlate with the multi-visceral involvement of the disease. Clin Exp Immunol. 2016;186(1):30–38.
   PubMed Web of Science ®Google Scholar
• Sono H, Matsuo K, Miyazato H, et al. A case of adult-onset Still’s disease complicated by non-Hodgkin’s lymphoma. Lupus. 2000;9(6):468–470.
   PubMed Web of Science ®Google Scholar
• Hofheinz K, Schett G, Manger B. Adult onset Still’s disease associated with malignancy-Cause or coincidence? Semin Arthritis Rheum. 2016;45(5):621–626.
   PubMed Web of Science ®Google Scholar
• Gallenga CE, Pandolfi F, Caraffa A, et al. Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents. 2019;33(1):1–6.
   PubMed Web of Science ®Google Scholar
• Gugliandolo A, Caraffa AL, Gallenga CE, et al. Mesenchymal stem cells and IL-37: a powerful combination. J Biol Regul Homeost Agents. 2019;33(4):1019–1022.
   PubMed Web of Science ®Google Scholar
• Avau A, Matthys P. Therapeutic potential of interferon-gamma and its antagonists in autoinflammation: lessons from murine models of systemic juvenile idiopathic arthritis and macrophage activation syndrome. Pharmaceuticals (Basel). 2015;8(4):793–815.
   PubMedGoogle Scholar
• Sui X. Inhibition of the NF-kappaB signaling pathway on endothelial cell function and angiogenesis in mice with acute cerebral infarction. J Biol Regul Homeost Agents. 2019;33(2):375–384.
   PubMed Web of Science ®Google Scholar
• Zuelgaray E, Battistella M, Vignon-Pennamen MD, et al. Cytokine levels in persistent skin lesions of adult-onset Still disease. J Am Acad Dermatol. 2018;79(5):947–949.
   PubMed Web of Science ®Google Scholar
• Konur A, Schulz U, Eissner G, et al. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Br J Dermatol. 2005;152(6):1134–1142.
   PubMed Web of Science ®Google Scholar
• Nistico S, Paolillo N, Minella D, et al. Effects of TNF-alpha and IL-1 beta on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes. Int J Immunopathol Pharmacol. 2010;23(4):1057–1072.
   PubMed Web of Science ®Google Scholar
• Lee H, Cheong KA, Kim JY, et al. IL-1 receptor antagonist reduced chemical-induced keratinocyte apoptosis through antagonism to IL-1alpha/IL-1beta. Biomol Ther (Seoul). 2018;26(4):417–423.
   PubMed Web of Science ®Google Scholar
• Grimstad O, Husebye H, Espevik T. TLR3 mediates release of IL-1beta and cell death in keratinocytes in a caspase-4 dependent manner. J Dermatol Sci. 2013;72(1):45–53.
   PubMed Web of Science ®Google Scholar
• Contassot E, Beer HD, French LE. Interleukin-1, inflammasomes, autoinflammation and the skin. Swiss Med Wkly. 2012;142:w13590.
   PubMed Web of Science ®Google Scholar
• Grimstad O, Sandanger O, Ryan L, et al. Cellular sources and inducers of cytokines present in acute wound fluid. Wound Repair Regen. 2011;19(3):337–347.
   PubMed Web of Science ®Google Scholar
• Grimstad O, Pukstad B, Stenvik J, et al. Oligodeoxynucleotides inhibit toll-like receptor 3 mediated cytotoxicity and CXCL8 release in keratinocytes. Exp Dermatol. 2012;21(1):7–12.
   PubMed Web of Science ®Google Scholar
• Feldmeyer L, Keller M, Niklaus G, et al. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol. 2007;17(13):1140–1145.
   PubMed Web of Science ®Google Scholar
• Renne J, Schafer V, Werfel T, et al. Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation. Br J Dermatol. 2010;162(6):1198–1205.
   PubMed Web of Science ®Google Scholar
• Sayama K, Yonehara S, Watanabe Y, et al. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J Invest Dermatol. 1994;103(3):330–334.
   PubMed Web of Science ®Google Scholar
• Matsue H, Kobayashi H, Hosokawa T, et al. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch Dermatol Res. 1995;287(3–4):315–320.
   PubMed Web of Science ®Google Scholar
• Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest. 2000;106(1):25–35.
   PubMed Web of Science ®Google Scholar
• Vitale A, Cavalli G, Colafrancesco S, et al. Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. Front Pharmacol. 2019;10:296.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Cipriani P, Masedu F, et al. Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers. BMC Med. 2016;14(1):194.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Iacono D, Ciccia F, et al. Macrophage activation syndrome in patients affected by adult-onset Still disease: analysis of survival rates and predictive factors in the gruppo italiano di ricerca in reumatologia clinica e sperimentale cohort. J Rheumatol. 2018;45(6):864–872.
   PubMed Web of Science ®Google Scholar